Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Micro Imaging Technology, Inc. (MMTC)
San Clemente, CA, US
Micro Imaging Technology, Inc. (MMTC) is a U.S.-based company focused on developing fluid monitoring solutions for the food safety and clinical industries. The firm is currently creating a rapid, laser-driven system designed to identify pathogenic bacteria efficiently. Additionally, MMTC collaborates with Northern Michigan University to explore novel methods for preparing pathogen samples, aiming to reduce test turnaround times to just 4 to 5 hours. Established in 1979, the company was formerly known as Electropure, Inc. before changing its name to Micro Imaging Technology, Inc. in November 2005. Its main offices are located in San Clemente, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -66.67% | -99.97% | -99.97% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%+61.5% ★ Q3'14: +40.0% (vs Q3'13)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%— Q3'14: +57.1% (vs Q3'13)
-
Share dilution Medical - Devices: 0.0%+102.8% Q3'14: +34.7% (vs Q3'13)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.33× Q3'14: -0.74× (vs Q3'13)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2010 | Michael Brennan/CEO | 180.0K | — | 294.3K | 1.7K | — | — | 478.0K | 61.93% | ↗ |
| 2 | 2010 | Victor Hollander/CFO | 120.0K | — | 260.0K | — | — | — | 380.0K | 68.42% | ↗ |
| 3 | 2009 | Michael Brennan/CEO | 180.0K | — | 423.2K | 14.8K | — | — | 618.1K | 70.86% | ↗ |
| 4 | 2009 | Victor Hollander/CFO | 120.0K | — | 200.6K | — | — | — | 320.6K | 62.57% | ↗ |
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Victor A. Hollander | Chief Financial Officer, Principal Accounting Officer & Director | 60.0K | male |
| David L. Haavig | Chief Scientist & Vice President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MMTC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
